*Doheny Eye Institute, University of California at Los Angeles, Los Angeles, California;
†Stein Eye Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles;
‡Department of Biomedical and Clinical Science “Luigi Sacco,” Eye Clinic, Sacco Hospital, University of Milan, Milan, Italy; and
§Department of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Reprint requests: SriniVas R. Sadda, MD, Department of Ophthalmology, Doheny Eye Institute, David Geffen School of Medicine at UCLA, 1355 San Pablo Street, Los Angeles, CA 90033; e-mail: [email protected]
S. A. Zweifel: (C) Allergan, (C, F) Bayer, (C, F) Novartis; S. R. Sadda: Amgen (C), Allergan (C), Genentech-Roche (C), Oxurion (C), Novartis (C), Regeneron (C), Bayer (C), 4DMT (C), Centervue (C, S), Heidelberg (C, F, S), Optos (C, F, S), Carl Zeiss Meditec (F, S), Nidek (S), Topcon (S). None of the other authors has any financial/conflicting interests to disclose.
All authors attest that they meet the current ICMJE criteria for authorship.
